Works matching IS 08857490 AND DT 2022 AND VI 37 AND IP 1
Results: 18
Adult human neurogenesis: early studies clarify recent controversies and go further.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Therapeutic potential of probiotics – Lactobacillus plantarum UBLP40 and Bacillus clausii UBBC07 on thioacetamide-induced acute hepatic encephalopathy in rats.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 185, doi. 10.1007/s11011-021-00862-w
- By:
- Publication type:
- Article
Quercetin mitigates scopolamine-induced memory dysfunction: impact on oxidative stress and cholinergic mechanisms.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 265, doi. 10.1007/s11011-021-00861-x
- By:
- Publication type:
- Article
Possible involvement of NO-sGC-cGMP signaling in the antidepressant like effect of pyridoxine in mice.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 173, doi. 10.1007/s11011-021-00858-6
- By:
- Publication type:
- Article
A novel probiotic strain exerts therapeutic effects on mouse model of multiple sclerosis by altering the expression of inflammasome and IDO genes and modulation of T helper cytokine profile.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 197, doi. 10.1007/s11011-021-00857-7
- By:
- Publication type:
- Article
Circular RNA circLIFR regulates the proliferation, migration, invasion and apoptosis of human vascular smooth muscle cells via the miR-1299/KDR axis.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 253, doi. 10.1007/s11011-021-00853-x
- By:
- Publication type:
- Article
A novel protein truncating mutation in L2HGDH causes L-2-hydroxyglutaric aciduria in a consanguineous Pakistani family.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 243, doi. 10.1007/s11011-021-00832-2
- By:
- Publication type:
- Article
Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Immune-microbiome interplay and its implications in neurodegenerative disorders.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Identification of methylation markers for diagnosis of autism spectrum disorder.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 219, doi. 10.1007/s11011-021-00805-5
- By:
- Publication type:
- Article
Serum fractalkine and 3-nitrotyrosine levels correlate with disease severity in Parkinson's disease: a pilot study.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 209, doi. 10.1007/s11011-021-00801-9
- By:
- Publication type:
- Article
Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
MALDI imaging mass spectrometry: an emerging tool in neurology.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 147, doi. 10.1007/s11011-021-00791-8
- By:
- Publication type:
- Article
Detection of structural and conformational changes in ALS-causing mutant profilin-1 with hydrogen/deuterium exchange mass spectrometry and bioinformatics techniques.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 1, p. 229, doi. 10.1007/s11011-021-00763-y
- By:
- Publication type:
- Article